,SARS-CoV-2 mRNA

Vanessa Proß1, Arne Sattler1, Sören Lukassen2

  • 1Department of General and Visceral Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

概括

接种SARS-CoV-2mRNA疫苗会在远离注射部位的器官中诱导组织内存T细胞. 这些细胞表现出增强的功能,有助于更广泛的免疫保护.